The implantable neurostimulation device activates the body's innate anti-inflammatory and immune-restorative pathways ...

The FDA just approved the SetPoint System, which electrically stimulates the vagus nerve to control inflammation from the ...

SetPoint System, newly approved by the FDA, can ease rheumatoid arthritis symptoms by delivering a small jolt of electricity ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.

Setpoint, which is based in Austin and New York, launched a $31 million Series B round led by Andreessen Horowitz, a storied Silicon Valley investor that has backed giants such as Airbnb, Slack ...

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid arthritis.The device is an implantable, integrated neurostimulator about the ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

The FDA has approved the SetPoint System, an implantable device that stimulates the vagus nerve to treat moderate-to-severe ...